Note: The Hamner Institute of Health Sciences closed it's doors on 12/31/16. This is an informative site to serve as an online record. The information on this website may not be accurate.

The Hamner History

The Hamner, initially known as Chemical Industry Institute of Toxicology, was an independent non-profit institute of health sciences founded by 11 chemical companies in the United States in the year 1974 to address the growing concerns on health. It was a research-based industry with its headquarters in Research Triangle Park, Durham of North Carolina, and the total number of employees was estimated to be 51-200 in number. Its principal purpose was to gauge the potential impact of chemicals on human health hence performing crucial research to improve chemical and drug safety. It also worked hard to speed the development of breakthrough drugs and were specialties in Genomics, Vivarium, chemical safety, drug safety, toxicology, Global partnership, Biosciences accelerator, computational modeling, and Translational research.

There were two leading institutes at The Hamner, namely The Institute for Chemical Safety Sciences and the Hamner-UNC Institute for Drug Safety. It was a 56-acre campus that involved in-depth research in toxicology and human health research and hence developing new cutting edge tools for assessment. As a multi-disciplinary organization, the Hamner speeded up the facilitation of life sciences technology among North Carolina universities. The campus experienced tremendous growth via a global partnership with academia, government, and industry. It always sought to advance science and, more specifically, life science.

It is remembered as a collaborative institution. It united the private sector, the government, and academia investing in biomedical research for both private and public sectors more effectively translated into products that improved human health. It offered the intellectual, collegial, and scientific benefits of a leading university. It collaborated with institutions such as the Critical Path Institute.

The organization impacted human health through the development of technologies such as silicon models for predictive toxicology, in vivo models to expose genes that play a role in vulnerability to drug-induced toxicities and in vitro models that utilize human cells to evaluate trepidations of cellular responses.

The Hamner is recorded to have been a force to reckon with, having been a leading organization in environmental health and safety sciences research. It also trained over 300 future talented and passionate scientists. The Hamner institute also had an Accelerator to support emerging companies and new institutes for translational Medicine to enhance its research. It served as a gateway to establish research collaborations with the pharmaceutical industry in Europe and Asia.

Multiple awards were won annually by the dedicated staff at The Hamner. This is because of the outstanding performance and discoveries by the institution. As if this is not enough, the chairperson of the board of directors at The Hamner was recognized with Health Care heroes with a lifetime achievement award. This was due to his contributions to the biosciences industry throughout the Southeast and also helped transform North Carolina into a flourishing biotechnology state.

As toxicologists, they had pronounced impacts on creating a safer and healthy world by helping regulate the non-toxic intensities of substances that are naturally harmful such as fluorides and caffeine, paying attention to the causes of the cancer menace and how ecological disclosures can be the sources of the same. The institution used Vitro analyses to gauge the toxicity of the liver and in determining the side effects of toxic substances to the kidney. They developed new and safer medicine whereby a potential human drug, a diagnostic agent, or a therapeutic device was transformed from a discovery into a medical product. It is for this very reason that the institute is said to have facilitated the modernization of the scientific process.

The Hamner institution that closed its doors in 2016 had recorded numerous achievements in the Southeast and, more specifically, in North Carolina and is registered as the leading institution for the development of the human health and medicinal products in life sciences.

The Hamner performs cutting-edge research to improve chemical and drug safety and speed the development of new breakthrough medicines.

The Hamner Institutes for Health Sciences brings together safety assessments for chemicals and drugs, world-class education and training, and accelerated technology development on a single, multidisciplinary campus in the heart of North Carolina's Research Triangle.

With a commitment to innovation, public-private partnerships, and the creation of a global biosciences gateway, The Hamner strives to be "the translational research model for the 21st century."

A FRAMEWORK FOR VISUALIZING TOXICITY PATHWAYS - The Hamner computational biology and bioinformatics team is developing new tools to make genomic data more intuitive.